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A hospital-based surveillance was undertaken
between May 2005 and April 2006 to elucidate
the contribution of Chandipura virus (CHPV) to
acute viral encephalitis cases in children, sero-
conversion in recovered cases and to compare
the seroprevalences of anti-CHPV IgM and N
antibodies in areas reporting cases with those
without any case of acute viral encephalitis.
During this period, 90 cases of acute encephalitis
were hospitalized in the pediatric wards of
Mahatma Gandhi Memorial (MGM) Hospital,
Warangal. There were 49 deaths (Case Fatality
Rate, i.e., CFR of 54.4%). Clinical samples and
records were obtained from 52 suspected cases.
The cases were below 15 years, majority in
0–4 years (35/52, 67.3%). Computerized tomo-
graphy (CT) scans and cerebro-spinal fluid (CSF)
picture favored viral etiology. No neurological
sequelae were observed. CHPV etiology was
detected in 25 cases (48.1%, n¼ 52; RNA in 20,
IgM in 3 and N antibody seroconversion in 2). JEV
etiology was detected in 5 cases (IgM in 4 cases
and seroconversion in 1 case). Anti-CHPV IgM
seroprevalence in contacts (26/167, 15.6%) was
significantly higher (P< 0.05) than in non-
contacts (11/430, 2.6%); which was also observed
in children <15 years (19/90, 21.1% vs. 3/109,
2.7%). Anti-CHPV N antibody seroprevalence in
<15 years contacts (66/90, 73.3%) and non-
contacts (77/109, 70.6%) was significantly lower
(P< 0.05) than in contacts (75/77, 97.4%) and
non-contacts (302/321, 94.1%) more than 15 years
respectively. CHPV appears to be the major cause
of acute viral encephalitis in children in endemic
areas during early monsoon months. J. Med.
Virol. 80:118–124, 2008.  2007Wiley-Liss, Inc.
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INTRODUCTION
Chandipura virus (CHPV), a vesiculovirus in the
Rhabdoviridae family, was associated with outbreaks
of acute encephalitis in children in various districts of
Andhra Pradesh in 2003 [Rao et al., 2004] and Gujarat
state in 2004 [Chadha et al., 2005]. These outbreaks
were characterized by rapid onset of fever, central
nervous system (CNS) involvement and high case
fataity. Probably, due to rapid onset of the disease, only
some cases had anti-CHPV IgM antibodies and hence
the polymerase chain reaction (PCR) was used for
diagnosis. The distribution of cases was patchy and the
villages reporting cases were far away from each other
making follow-up of cases a difficult task. Therefore,
data on seroconversion in recovered cases were crucial.
During these outbreaks, anti-CHPV IgM antibodies
were detected in some cases of fever, healthy family
contacts and other individuals in the community indi-
cating wider disease spectrum with the possibility of
subclinical infections [Chadha et al., 2005]. The pres-
ence of anti-CHPV IgG antibodies in adults [Rao et al.,
2004] and high frequency of neutralizing (N) antibodies,
with increase in seroprevalenceswith age in the healthy
human population [Chadha et al., 2005] suggested that
the virus was endemic in the area.
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The study was planned to determine the contribution
of CHPV to acute viral encephalitis cases in children,
seroconversion in recovered cases and to compare the
seroprevalences of anti-CHPV IgM and N antibodies in
areas reporting cases with those without any cases of
acute viral encephalitis.
METHODS
The study area, the northTelangana region ofAndhra
Pradesh state (Fig. 1), has the regional directorate of
health services and the referral medical college hospital
in Warangal city, serving the population of Warangal,
Karimnagar, Khammam, and Adilabad districts. The
general population density is 252 per square kilometers
with 81% of the population residing in rural areas.
A hospital-based surveillance of cases with acute
encephalitis in children, admitted to the Mahatma
Gandhi Memorial Hospital of KakatiyaMedical College
in Warangal city, was undertaken between May 2005
and April 2006. An acute viral encephalitis case was
defined as a patient aged less than 15 years, presenting
with acute onset of fever and central nervous system
involvement in the form of one or more symptoms such
as altered sensorium, unconsciousness, coma and con-
vulsions; without signs of meningeal involvement; and
negative for malaria, tuberculosis and other common
bacterial causes. Clinico-epidemiological field investi-
gations were undertaken through the field station
established by the National Institute of Virology (NIV),
Pune (India).
Fifty-two acute viral encephalitis cases, including
three caseswith acute onset of neurological involvement
but without any records of fever were studied. Acute
phase sera were collected within a week of the onset of
illness. Convalescent phase sera were collected between
2 and 7 weeks (n¼ 9) and after 3 months (n¼2) of the
onset of illness. A total of 167 sera from contacts residing
in 10 villages reporting at least one case of acute viral
encephalitis and 430 sera from subjects residing in
11 villages without any case (non-contacts) were collec-
ted for detection and comparison of viral activity.
Detection of CHPV RNA was done according to the
method described earlier [Chadha et al., 2005]. PCR
positivity was confirmed by sequencing all the PCR
products. Alternate negative controls were included in
all the PCR assays. Pre- and post-amplification proce-
dures were conducted in well-segregated laboratories.
J. Med. Virol. DOI 10.1002/jmv
Fig. 1. Geographic distribution of acute viral encephalitis cases among children in North Telangana,
Andhra Pradesh, India (May 9, 2005 to March 22, 2006, N¼52). The affected districts with the number of
reported cases in brackets.
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Patient sera were screened using in-house enzyme-
linked immunosorbent assays (ELISAs) for the detec-
tion of IgM antibodies against Japanese Encephalitis
virus (JEV), West Nile virus (WNV), and CHPV [Rao
et al., 2004]. Negative controls included age-matched
sera from apparently healthy children from an area not
affected by the outbreak, and serum and CSF from
children with flavivirus encephalitis. The cut-off value
was determined as mean optical density for negative
controls plus 3 SD.
Similarly, all sera were screened for neutralizing (N)
antibodies against CHPV employing an in vitro neu-
tralization test in Porcine Sarcoma (PS) cell cultures as
per the protocol described previously [Rao et al., 2004].
The virus neutralizing antibody titer was expressed as
the reciprocal of the highest antibody dilution capable of
neutralizing 100 TCID50 of CHPV. A titer of 1:10 was
considered a positive result.
The proportions of contacts and non-contacts showing
neutralizing (N) antibody were compared using Chi-
square. The Institutional Ethical Committee approved
the study protocol for clinical case investigations,
laboratory diagnosis and seroepidemiological surveys
in contacts and non-contacts.
RESULTS
According to the records of the hospital, betweenMay
2005 and April 2006, 90 cases of encephalitis were
admitted in the hospital, among which 49 were deaths
(CFR 54.4%). Clinical data and the sera were obtained
from 70 cases, out of which 52 patients were consid-
ered as suspects as per the case definition. As depicted
in Figure 1, the majority of these cases were from
Warangal district (42 cases), followed by other districts
(Karimnagar-8 cases, Khammam-1 case, Adilabad-1
case). Clustering was not observed. The summary sheet
of these 52 suspect patients is shown in Table I.
The ages of the patients ranged between9months and
13 yearswithmaximumcases (35/52, 70%) in 0–4 years.
Male to female ratio was 1:2. Case fatality was high
(25/52, 48.1%) and majority of deaths (19/25, 76%)
occurred within 48 hr of hospitalization. Hospital stay
in survivors ranged between 2 and 9 days without any
neurological sequelae at discharge from hospital and
even at follow-up in the field in 11 cases. Acute onset of
fever was reported in 49 of 52 cases, with duration
less than 48 hr in majority (29/52, 54%). The symptoms
included various degrees of altered consciousness (47/
52, 90.4%) and convulsions (41/52, 78%). Other common
symptoms included vomiting (23/52, 44%) and diarrhea
(8/52, 16%).
Clinical neurological examination revealed decreased
muscle tone and power with non-elicitable deep tendon
reflexes and extensor plantar responses. Pupils were
dilated with a sluggish reaction to light. Ocular fundi
were normal in 2 patients. CT scans of 8 cases revealed
diffuse swelling of the brain parenchyma and dilated
ventricles. Routine laboratory evaluation was negative
for malaria, tuberculosis and other common bacterial
infections. CSF in 13 cases showed raised intra-cranial
pressure, with normal glucose and slightly raised
protein levels. There were no organisms and cells
were less than 5 per cubic millimeter, predominantly
lymphocytes.
The biweekly distribution of cases is shown in
Figure 2. The bimodality in the epidemiological curve
reflects exclusive CHPV cases (20/34, 58.8%) in early
period and second rise of CHPV (5/18, 27.8%) with JEV
(5/18, 27.8%) cases occurring after 15th September
2005. The differences in clinical presentations of CHPV
and JEV confirmed cases are described in the following
paragraph.
Twelve of 25 (48.0%) CHPV cases occurred in children
under 5 years of age as compared to none of 5 JEV cases.
Also, 8 out of 10 deaths among 25 CHPV cases occurred
within 24 hr of the onset of illness, whereas there were
no deaths among5 JEVpatients. Seventeen of 25 (68.0%)
CHPV cases presented with history of fever less than
2 days and none in JEV cases. CSF cell counts were
less than 2 per cubic millimeter in CHPV cases, while in
JEV cases the cells ranged from 90 to 300. CSF protein
levels in investigated CHPV cases were normal and
in JEV cases these were raised. The CT scan images
of twoCHPV cases are shown in Figure 3. The ventricles
were dilated in one case (Fig. 3a, case no. 9 in Table I
and case no. 3 in Table II). Diffuse swelling of the
white matter and effaced sulcal spaces were suggestive
of infective etiology in the second case (Fig. 3b, case
no. 12 in Table I and case no. 4 in Table II), which
reported convulsions of acute onset without a history of
fever.
CHPVRNAwas detected in 20 (45.4%) of 44 cases and
anti-CHPV IgM in 3 (6.8%) cases (Table I). Seroconver-
sion was studied in 11 cases (Table II). Among five cases
with evidence ofCHPVRNAbyPCR inacute phase sera,
CHPV seroconversion was found in four cases—anti-
CHPV IgM seroconversion (case no. 3), anti-CHPV N
antibody seroconversion (case no. 1) and both anti-
CHPV IgM and N antibody seroconversion in two cases
(case no. 5 and 6). Two more cases, which were negative
for both CHPV RNA and anti-CHPV IgM in the acute
phase sera, seroconverted to anti-CHPV N antibodies
(case no. 4 and 7) in the convalescent phase sera. Thus
CHPV etiology was detected in 25 cases. Among these,
20 (8%) cases were reported between 9th May and 15th
September 2005, the period of late summer and early
monsoon seasons.
Anti-JEV IgM was detected in 4 of 37 (10.8%) invest-
igated cases. One more case (Table II—case no. 10)
seroconverted to anti-JEV IgM. All these 5 JEV cases
were reported after 15th September 2005, which is the
late monsoon season. In summary, among 52 cases,
25 (48.1%) cases were detected with CHPV etiology and
5 (9.6%) cases with JEV etiology. Thus, viral etiology
could be established in 30 (57.7%) of 52 cases.
The comparisons of seropositivity to anti-CHPV
IgM and N antibodies between contacts and non-
contacts according to age groups are shown in
Table III. Anti-CHPV IgM antibody seropositivity
J. Med. Virol. DOI 10.1002/jmv
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Fig. 3. Computerized tomographic (CT) scan images of two CHPV confirmed cases. a: Shows dilated
temporal horns of both lateral ventricles (indicated by an arrow) in a section at suprasellar cistern.
b: Shows diffuse white matter edema on both sides and effaced sulcal spaces in a section at the
supraventricular region.
Fig. 2. Biweekly incidence of acute viral encephalitis cases among children inNorth Telangana, Andhra
Pradesh, India (May 9, 2005 toMarch 22, 2006, N¼ 52). The numbers of cases are indicated on Y-axis, with
the etiology indicated as JEV, CHPVandunknown, in decreasing shades of gray. X-axis shows the starting
date of 2 weeks period.
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in contacts (26/167, 15.6%) was significantly higher
(P<0.05) than in non-contacts (11/430, 2.6%). Anti-
CHPV IgM antibody seropositivity in contacts aged less
than 15 years (19/90, 21.1%) was significantly higher
(P<0.05) than contacts aged 15 years or more (7/77,
9.1%).Feverwas reportedby9 (5.4%)of 167contacts and
21 (4.9%) of 430 non-contacts, among which anti-CHPV
IgM was detected in 2 of 9 febrile contacts and 3 of
21 febrile non-contacts. Anti-CHPV IgM seropositivity
in afebrile contacts (24/158, 15.2%) was significantly
higher (P< 0.05) than afebrile non-contacts (8/409,
1.9%).
Anti-CHPV N antibody seropositivity in children less
than 15 years contacts (66/90, 73.3%) and non-contacts
(77/109, 70.6%) was significantly less (P< 0.05) than in
more than 15 years contacts (75/77, 97.4%) and non-
contacts (302/321, 94.1%) respectively.
DISCUSSION
Of the 52 suspected cases of viral encephalitis in
children, evidence of recent viral infection was estab-
lished conclusively in 30 (57.7%) cases. CHPV infection
was detected in 25 (48.1%) cases with the majority
(20 cases) in late summer and the earlymonsoon season.
JEV infection was detected in 5 (9.6%) cases, all 5 cases
detected after 15th September 2005, indicating differ-
ent periods of JEV and CHPV activity. Warangal
and Karimnagar districts have been identified as JEV
endemic areas with occurrence of encephalitis cases
in the late monsoon season. Over all, 25 cases could
be attributed to CHPV, 5 cases to JEV and 22 cases
remained undiagnosed.
It is important to note that due to rapid onset andhigh
mortality, CHPV diagnosis is basedmainly on detection
of CHPVRNA. Though 19 of 22 undiagnosed cases were
bled during the acute phase, CHPV RNA negativity in
these samples could be due to the absence of viremia at
sampling or the presence below the detection limit of the
nested PCR. The possibility of circulation of another
agent cannot be ruled out. Three undiagnosed cases
were bled during the second week of illness. The late
development of anti-CHPV IgM antibodies in few cases,
less sensitivity of the assay used currently or other
etiology may be possible in these cases. Follow up of
11 cases provided important information in relation to
J. Med. Virol. DOI 10.1002/jmv
TABLE III. Age-Specific Seroprevalences of Anti-CHPV IgM and N Antibodies in Contacts and Non-Contacts
Type of antibody Anti-CHPV IgM antibody Anti-CHPV N antibody
Subject category Contacts Non-contacts Contacts Non-contacts
Age <15 years 19/90 (21.1) 3/109 (2.7) 66/90 (73.3) 77/109 (70.6)
Age 15years 7/77 (9.1) 8/321 (2.5) 75/77 (97.4) 302/321 (94.1)
Total 26/167 (15.6) 11/430 (2.6) 141/167 (84.4) 379/430 (88.1)
Figures indicate No. positive/No. Tested (percentage).
TABLE II. Seroconversion to Anti-CHPV IgM and N Antibodies and Anti-JEV IgM
Case no.
Post onset day
of serum CHPV RNA
Anti-CHPV
IgM
Anti-CHPV N
antibody result
Anti-CHPV N
antibody titer Anti-JEV IgM
1a 3 Pos Neg Neg <1:10 —
111 — Neg Pos 1:80 Neg
2 6 Neg Neg Neg <1:10 Neg
17 — Neg Neg <1:10 Neg
3a 6 Pos Neg Pos 1:80 Neg
17 — Pos Pos 1:80 Neg
4a 3 Neg Neg Neg <1:10 —
120 — Neg Pos 1:160 Neg
5a 0 Pos Neg Neg <1:10 Neg
16 — Pos Pos 1:640 Neg
6a 1 Pos Neg Neg <1:10 Neg
16 — Pos Pos 1:320 Neg
7a 2 Neg Neg Neg <1:10 Neg
12 — Neg Pos 1:160 Neg
8 4 — Neg — — Pos
38 — Neg Neg <1:10 Pos
9 6 Pos Neg Pos 1:40 Neg
42 — Neg Pos 1:40 —
10a 5 Neg Neg Pos 1:40 Neg
21 — Neg Pos 1:80 Pos
11 8 — Neg Neg <1:10 Neg
23 Neg Neg Neg <1:10 —
aIndicates cases with seroconversion.
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the possibility of misdiagnosis based on a single serum
sample (Table II).
The clinical features were consistent with those
described in 28 confirmed cases in Andhra Pradesh
outbreak [Rao et al., 2004] and 19 cases in Gujarat
[Chadha et al., 2005]. The CFR of 54%was also similar to
that observed in the 2003 outbreak [Rao et al., 2004]. The
results confirmconclusively the role of CHPVas themajor
cause of endemic acute viral encephalitis in children from
the Telangana region of Andhra Pradesh.
Detection of anti-CHPV N antibody seropositivity to
similar extent in villages reporting and not reporting
encephalitis cases shows that the virus is highly
prevalent in the region (Table III). The presence of
anti-CHPV IgM antibodies in 2 of 9 febrile contacts and
3 of 21 febrile non-contacts indicate the varied clinical
spectrumof theCHPV infection. The factors responsible
for encephalitis in some children need to be examined.
Exposure of children below 15 years of age, as deter-
mined by the presence of anti-CHPV N antibodies, was
significantly less than adults indicating susceptibility
of pediatric population. This is consistent with the fact
that encephalitis cases occurred only among children as
observed earlier [Rao et al., 2004; Chadha et al., 2005].
Sand flies have been implicated as vectors of CHPV
by isolations in Aurangabad [Dhanda et al., 1970] and
detection of viral RNA in Karimnagar [Geevarghese
et al., 2005].
Thus, CHPV is an important cause of endemic acute
viral encephalitis in children in Telangana region of
Andhra Pradesh with seasonal increase in early mon-
soon. Proper surveillance and vector control strategies
may help in case reduction.
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